Orthocell’s nerve repair product Remplir posts near-90pc success rate as global rollout gains momentum

Data to support continued US expansion and planned European market entry, with approval targeted for H2 CY26 ... Read More The post Orthocell’s nerve repair product Remplir posts near-90pc success rate as global rollout gains momentum appeared first on Stockhead .

Go to News Site